Design, Fabrication, and Application of Mini-Scaffolds for Cell Component in Tissue Engineering

publishersversionPeer reviewe

Luminescent coordination polymers based on Ca²⁺ and octahedral cluster anions [{M₆Clⁱ₈}Clᵃ₆}²⁻ (M = Mo, W) : synthesis and thermal stability studies

Luminescent coordination polymers (CPs) based of inexpensive stable precursors are attractive materials for applications. Here we report the synthesis and evaluation of the stability and photophysical characteristics of the first examples of phosphorescent CPs based on octahedral molybdenum and tungsten cluster anions. Specifically 1D CP trans-[{Ca(OPPh₃)₄}{{M₆Clⁱ₈}Clᵃ₆}]∞ (M = Mo, W) can be obtained either directly at increased temperature or via intermediate phases [cis-Ca(OPPh₃)₄(H₂O)₂][{M₆Clⁱ₈}Clᵃ₆]∙2CH₃CN that are stable at room-temperature, but convert to the titled CP at temperatures above 100 °C

Nanotechnological strategies for biofabrication of human organs

Nanotechnology is a rapidly emerging technology dealing with so-called nanomaterials which at least in one dimension have size smaller than 100nm. One of the most potentially promising applications of nanotechnology is in the area of tissue engineering, including biofabrication of 3D human tissues and organs. This paper focused on demonstrating how nanomaterials with nanolevel size can contribute to development of 3D human tissues and organs which have macrolevel organization. Specific nanomaterials such as nanofibers and nanoparticles are discussed in the context of their application for biofabricating 3D human tissues and organs. Several examples of novel tissue and organ biofabrication technologies based on using novel nanomaterials are presented and their recent limitations are analyzed. A robotic device for fabrication of compliant composite electrospun vascular graft is described. The concept of self-assembling magnetic tissue spheroids as an intermediate structure between nano- and macrolevel organization and building blocks for biofabrication of complex 3D human tissues and organs is introduced. The design of in vivo robotic bioprinter based on this concept and magnetic levitation of tissue spheroids labeled with magnetic nanoparticles is presented. The challenges and future prospects of applying nanomaterials and nanotechnological strategies in organ biofabrication are outlined.publishersversionPeer reviewe

Organ printing as an information technology

Funding Information: This work has been sponsored by the São Paulo Research Foundation (FAPESP), The Brazilian Institute of Biofabrication (INCT-BIOFABRIS) and National Council for Scientific and Technological Development (CNPq). Publisher Copyright: © 2015 Published by Elsevier Ltd.Organ printing is defined as a layer by layer additive robotic computer-aided biofabrication of functional 3D organ constructs with using self-assembling tissue spheroids according to digital model. Information technology and computer-aided design softwares are instrumental in the transformation of virtual 3D bioimaging information about human tissue and organs into living biological reality during 3D bioprinting. Information technology enables design blueprints for bioprinting of human organs as well as predictive computer simulation both printing and post-printing processes. 3D bioprinting is now considered as an emerging information technology and the effective application of existing information technology tools and development of new technological platforms such as human tissue and organ informatics, design automation, virtual human organs, virtual organ biofabrication line, mathematical modeling and predictive computer simulations of bioprinted tissue fusion and maturation is an important technological imperative for advancing organ bioprinting.publishersversionPeer reviewe

Tensiometric estimation of material properties of tissue spheroids

Tissue spheroids have been proposed to use as building blocks in biofabrication and as bioinks in 3D bioprinting technologies. Tissue fusion is an ubiqious phenomenon during embryonic development. Biomimetic tissue spheroid fusion is a fundamental constructional principle of emerging organ printing technology because closely placed tissue spheroids could fuse into tissue and organ-like constructs in fusion permissive bioprintable hydrogel. From physical point of view tissue spheroids could be considered as a visco-elastic-plastic soft matter or complex fluid. We hypothesize that quantitative estimation of material properties of tissue spheroids using tensiometry could predict their tissue spreading and tissue fusion behavior as well as provide a powerful insight about possible speed of post-printed tissue and organ-like constructs compaction and maturation. Tissue spheroids from human fibroblasts, ovine and human chondrocytes and immortalised human keratinocytes have been biofabricated using non-adhesive cell culture plates (Corning, USA). For estimation of material properties of tissue spheroids commercial tensiometer Microsquisher have been emploied (CellScale, Toronto, Canada). Modulus of elasticity of tissue spheroids have been calculated based on peformed tissue compression tests. In order to identify structural determinants of material properties of tissue spheroids standard perturbants of cytoskeleton such as Cytochalasin D (Sigma, USA) for disruption of microfilaments and Nocodazole (Sigma, USA) for disruption of microtubules have been used. Viability of tissue spheroids have been also estimated and their morphology have been analysed using light microscopy, histochemistry, immunohistochemistry, semithin sections stained wih toluidine blue and transmission and scanning electron microscopy. Kinetics of tissue spheroids spreading on electrospun polyurethane matrices have been analysed. Kinetics of two closely placed tissue spheroids fusion have been analysed in hanging drop. Additionally toxic effect of water solution of paramagnetic gadolinium salt (Omniscan®, GE Health Care, USA) on material properties of tissue spheroids have been investigated. It have been demonstrated that material properties of tissue spheroids biofabricated from different cell types have different modulus of elasticity. Even tissue spheroids biofabricated the same cell types but from different species have different material properties. Incubation with Cytochlasin D dramatically reduces estimated material properties of tissue spheroids. Incubation with Nocodazole does not significantly change material properties of tissue spheroids. Material properties of tissue spheroids from chondrocytes (chondrospheres) correlates very well with increasing deposition and accumulation of extracellular matrix (confirmed by expression of collagen type II and glycosoaminoglycans). The incubation with toxic concentration of gadolinium solution dramatically reduces material properties of chondrospheres. There is no any significant correlation between material properties of tissue spheriods and their spreading kinetics. However, there is a certain correction between material properties of tissue spheroids and their tissue fusion kinetics. Our data demonstrate that beside already well established role of cell adhesion receptors such as cadherin and integrins in the realisation of cell cohesion inside tissue spheroids the structural determinants of material properties of tissue spheroids also include components of cytoskeleton such as actin micofilaments and accumulated extracellular matrix. It is possible to predict post-printing tissue fusion behaviour of tissue spheroids based on preliminary estimation of their material properties. Finally, it have been also shown that material properties of tissue spheroids correlate with their viability. Thus, tensiometry is a valuable method for systematic characterization of material properties of tissue spheroids and for prediction of tissue spheroids post-printed tissue fusion behaviour

Structure- and interaction-based design of anti-SARS-CoV-2 aptamers

Aptamer selection against novel infections is a complicated and time-consuming approach. Synergy can be achieved by using computational methods together with experimental procedures. This study aims to develop a reliable methodology for a rational aptamer in silico et vitro design. The new approach combines multiple steps: (1) Molecular design, based on screening in a DNA aptamer library and directed mutagenesis to fit the protein tertiary structure; (2) 3D molecular modeling of the target; (3) Molecular docking of an aptamer with the protein; (4) Molecular dynamics (MD) simulations of the complexes; (5) Quantum-mechanical (QM) evaluation of the interactions between aptamer and target with further analysis; (6) Experimental verification at each cycle for structure and binding affinity by using small-angle X-ray scattering, cytometry, and fluorescence polarization. By using a new iterative design procedure, structure- and interaction-based drug design (SIBDD), a highly specific aptamer to the receptorbinding domain of the SARS-CoV-2 spike protein, was developed and validated. The SIBDD approach enhances speed of the high-affinity aptamers development from scratch, using a target protein structure. The method could be used to improve existing aptamers for stronger binding. This approach brings to an advanced level the development of novel affinity probes, functional nucleic acids. It offers a blueprint for the straightforward design of targeting molecules for new pathogen agents and emerging variant

Can Routine Commercial Cord Blood Banking Be Scientifically and Ethically Justified?

Background to the debate: Umbilical cord blood—the blood that remains in the placenta after birth—can be collected and stored frozen for years. A well-accepted use of cord blood is as an alternative to bone marrow as a source of hematopoietic stem cells for allogeneic transplantation to siblings or to unrelated recipients; women can donate cord blood for unrelated recipients to public banks. However, private banks are now open that offer expectant parents the option to pay a fee for the chance to store cord blood for possible future use by that same child (autologous transplantation.

Commercial articulated collaborative in situ 3D bioprinter for skin wound healing

In situ bioprinting is one of the most clinically relevant techniques in the emerging bioprinting technology because it could be performed directly on the human body in the operating room and it does not require bioreactors for post-printing tissue maturation. However, commercial in situ bioprinters are still not available on the market. In this study, we demonstrated the benefit of the originally developed first commercial articulated collaborative in situ bioprinter for the treatment of full-thickness wounds in rat and porcine models. We used an articulated and collaborative robotic arm from company KUKA and developed original printhead and correspondence software enabling in situ bioprinting on curve and moving surfaces. The results of in vitro and in vivo experiments show that in situ bioprinting of bioink induces a strong hydrogel adhesion and enables printing on curved surfaces of wet tissues with a high level of fidelity. The in situ bioprinter was convenient to use in the operating room. Additional in vitro experiments (in vitro collagen contraction assay and in vitro 3D angiogenesis assay) and histological analyses demonstrated that in situ bioprinting improves the quality of wound healing in rat and porcine skin wounds. The absence of interference with the normal process of wound healing and even certain improvement in the dynamics of this process strongly suggests that in situ bioprinting could be used as a novel therapeutic modality in wound healing.publishersversionPeer reviewe

Development of methods of phosphorylation of citral by medial and acidic phosphites

The reactions of trimethyl phosphite with citral in the presence of acetic acid, triphenyl phosphite with citral in the presence of water and trimethyl phosphite with citral in the presence of water and triethylamine in the methanol solution were studied. On the basis of these studies, dienyl 1-hydroxyphosphonates were obtained. A convenient method of synthesizing unsaturated 1-hydroxyphosphonates was developed on the basis of reaction of dialkyl phosphites with citral in the presence of triethylamine in molar ratio 4:2:8 in alcohol solutions